Works:
- STAT3 and PIM1 as potential targets for glioblastoma treatment
- Sorafenib sensitizes glioma cells to the BH3 mimetic ABT-737 by targeting MCL1 in a STAT3-dependent manner
- Glioblastoma tissue slice tandem-cultures for quantitative evaluation of inhibitory effects on invasion and growth
- STAT3 enhances sensitivity of glioblastoma to drug-induced autophagy-dependent cell death